GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medexus Pharmaceuticals Inc (FRA:P731) » Definitions » Tax Provision

Medexus Pharmaceuticals (FRA:P731) Tax Provision : €0.3 Mil (TTM As of Dec. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Medexus Pharmaceuticals Tax Provision?

Medexus Pharmaceuticals's tax provision for the three months ended in Dec. 2024 was €-0.1 Mil. Its tax provision for the trailing twelve months (TTM) ended in Dec. 2024 was €0.3 Mil.

Medexus Pharmaceuticals Tax Provision Historical Data

The historical data trend for Medexus Pharmaceuticals's Tax Provision can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medexus Pharmaceuticals Tax Provision Chart

Medexus Pharmaceuticals Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Tax Provision
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.76 2.72 0.85 5.85 -0.29

Medexus Pharmaceuticals Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Tax Provision Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.24 -0.21 0.05 0.62 -0.14

Medexus Pharmaceuticals Tax Provision Calculation

Tax to be paid.

Tax Provision for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.3 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medexus Pharmaceuticals Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medexus Pharmaceuticals Inc (FRA:P731) » Definitions » Tax Provision
Comparable Companies
XCNQ:JUSH TSXV:SBBC TSX:XLY XCNQ:AAWH.U TSXV:HASH TSXV:LOVE XCNQ:AYR.A XCNQ:IAN XCNQ:INNO TSXV:ZYUS ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD XSWX:SDZ XTAE:TEVA NSE:DIVISLAB HKSE:03692
Traded in Other Exchanges
MEDXF:USA MDP:Canada
Address
10 King Street East, Suite 600, Toronto, ON, CAN, M5C 1C3
Website
https://www.medexus.com
Medexus Pharmaceuticals Inc is a specialty pharmaceutical company with a powerful North American commercial platform and a growing portfolio of inventive and rare disease treatment solutions. The company's focus is on the therapeutic areas of oncology, hematology, rheumatology, auto-immune diseases, allergy, and dermatology.

Medexus Pharmaceuticals Headlines

No Headlines